Evidence map›Paper›PMID 37194957›Full record

ArticleThe British journal of psychiatry : the journal of mental science2023

Use of cognitive remediation to treat negative symptoms in schizophrenia: is it time yet?

Rafael Penadés, Til Wykes

Open access · bronzeAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in The British journal of psychiatry : the journal of mental science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Rafael PenadésBarcelona Clinic Schizophrenia Unit, Hospital Clínic Barcelona Spain; Department of Clinical Psychology and Psychobiology, University of Barcelona, Sain IDIBAPS, CIBERSAM, Barcelona, Spain.ORCID 0000-0002-1564-3717
Til WykesInstitute of Psychiatry, Psychology and Neuroscience, King's College London. South London and Maudsley NHS Foundation Trust, London, UK.ORCID 0000-0002-5881-8003
Centro de Investigación Biomédica en Red de Salud Mental · ESKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive remediation is currently recommended to treat cognitive and functional impairments in patients with schizophrenia. Recently, treatment of negative symptoms has been proposed as a new target for cognitive remediation. Evidence of reductions in negative symptoms has been described in different meta-analyses. However, treating primary negative symptoms is still an open question. Despite some emerging evidence, more research focused on individuals with primary negative symptoms is indispensable. In addition, more attention to the role of moderators and mediators and the use of more specific assessments is necessary. Nevertheless, cognitive remediation could be considered as one promising option to treat primary negative symptoms.

Indexed as

Cognition DisordersCognitive Behavioral TherapyCognitive RemediationSchizophreniaHumansSchizophrenic Psychologycognitive–behavioural therapiesindividual psychotherapypsychotic disordersrehabilitationSchizophrenia

Identifiers

PMID37194957
OpenAlexW4376872950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.